[SY1-5]Phosphorylated Tau Targeted Passive & Active Immunotherapy in Alzheimer’s Disease
○Lennert Steukers1, Ziad Saad2, Gallen Triana-Baltzer2(1.Janssen Pharmaceutica NV, a Johnson & Johnson company Beerse, Belgium, 2.Janssen Research & Development LLC, a Johnson & Johnson company La Jolla, USA, 3.Janssen Research & Development LLC, a Johnson & Johnson company Titusville, USA)
Password required to view
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.
Password is required to view the abstract. Please enter a password to authenticate.